California State Teachers Retirement System (CalSTRS)
RNAC icon

California State Teachers Retirement System (CalSTRS)’s Cartesian Therapeutics RNAC Stock Holding History

California State Teachers Retirement System (CalSTRS)’s Portfolio RNAC Stock Details RNAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.49K Sell
567
-78
-12% -$556 ﹤0.01% 2884
2025
Q4 		$4.65K Sell
645
-122
-16% -$986 ﹤0.01% 2969
2025
Q3 		$7.84K Buy
767
+1
+0.1% +$11 ﹤0.01% 2913
2025
Q2 		$7.96K Hold
766
– – ﹤0.01% 2814
2025
Q1 		$10.1K Hold
766
– – ﹤0.01% 2763
2024
Q4 		$13.7K Buy
766
+242
+46% +$4.9K ﹤0.01% 2748
2024
Q3 		$8.45K Hold
524
– – ﹤0.01% 2926
2024
Q2 		$14.2K Buy
524
+321
+158% +$7.66K ﹤0.01% 2747
2024
Q1 		$3.96K Sell
203
-442
-69% -$9.37K ﹤0.01% 3013
2023
Q4 		$13.3K Sell
645
-209
-24% -$6.24K ﹤0.01% 2969
2023
Q3 		$27.2K Sell
854
-434
-34% -$14.5K ﹤0.01% 2927
2023
Q2 		$43.3K Buy
+1,288
New +$46.1K ﹤0.01% 2969
2022
Q2 		– Sell
-1,308
Closed -$48K – 3275
2022
Q1 		$48K Sell
1,308
-373
-22% -$23.3K ﹤0.01% 3045
2021
Q4 		$164K Hold
1,681
– – ﹤0.01% 2854
2021
Q3 		$210K Sell
1,681
-2,427
-59% -$293K ﹤0.01% 2724
2021
Q2 		$515K Buy
4,108
+700
+21% +$83.4K ﹤0.01% 2620
2021
Q1 		$463K Hold
3,408
– – ﹤0.01% 2551
2020
Q4 		$310K Hold
3,408
– – ﹤0.01% 2642
2020
Q3 		$254K Hold
3,408
– – ﹤0.01% 2618
2020
Q2 		$290K Buy
+3,408
New +$309K ﹤0.01% 2520
2019
Q2 		– Sell
-1,767
Closed -$126K – 3072
2019
Q1 		$126K Buy
1,767
+790
+81% +$50.1K ﹤0.01% 2868
2018
Q4 		$78K Buy
977
+59
+6% +$13.5K ﹤0.01% 2952
2018
Q3 		$428K Hold
918
– – ﹤0.01% 2535
2018
Q2 		$365K Buy
918
+201
+28% +$71.3K ﹤0.01% 2626
2018
Q1 		$219K Sell
717
-20
-3% -$5.7K ﹤0.01% 2760
2017
Q4 		$217K Sell
737
-16
-2% -$6.99K ﹤0.01% 2799
2017
Q3 		$412K Buy
753
+60
+9% +$31.9K ﹤0.01% 2510
2017
Q2 		$413K Buy
693
+343
+98% +$152K ﹤0.01% 2572
2017
Q1 		$150K Hold
350
– – ﹤0.01% 2875
2016
Q4 		$180K Sell
350
-10
-3% -$5.84K ﹤0.01% 2881
2016
Q3 		$154K Buy
+360
New +$141K ﹤0.01% 2914

Other funds holding RNAC

Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS)'s RNAC Position: Q1 2026 in Review

California State Teachers Retirement System (CalSTRS) reduced its Cartesian Therapeutics (RNAC) stake by 12% in Q1 2026, selling an estimated $556 and leaving 567 shares worth $3.49K. The position accounts for ﹤0.01% of the portfolio, ranked #2884.

California State Teachers Retirement System (CalSTRS) first reported a position in RNAC in Q3 2016 and has held it in 31 quarters since. The position peaked at $515K in Q2 2021. 83 funds tracked by Wall St. Rank hold RNAC as of Q1 2026.

  • California State Teachers Retirement System (CalSTRS) held 567 shares of Cartesian Therapeutics worth $3.49K as of Q1 2026.
  • California State Teachers Retirement System (CalSTRS) sold 78 Cartesian Therapeutics shares in Q1 2026, an estimated $556.
  • Cartesian Therapeutics made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q1 2026, its #2884 holding.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Cartesian Therapeutics in Q3 2016 and has held it in 31 quarters since.
  • California State Teachers Retirement System (CalSTRS)'s Cartesian Therapeutics position peaked at $515K in Q2 2021.
  • 83 funds tracked by Wall St. Rank held Cartesian Therapeutics as of Q1 2026.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q1 2026, filed 18 May 2026.